Quality of life (QOL) among patients (pts) with HER2+ breast cancer (bc) treated with adjuvant lapatinib and/or trastuzumab in the ALTTO study (BIG 2-06, Alliance N063D). Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Dueck, Amylou C
  • Hillman, David W
  • Kottschade, Lisa A
  • Halyard, Michele Y
  • Sloan, Jeff A
  • Flickinger, Lynn M
  • Wolff, Antonio C
  • Harris, Lyndsay
  • Gralow, Julie
  • Pritchard, Kathleen
  • Ellard, Susan
  • Le-Lindqwister, Nguyet
  • Boyle, Frances M
  • De Azambuja, Evandro
  • McCaskill-Stevens, Worta J
  • Zujewski, Jo Anne
  • Piccart-Gebhart, Martine J
  • Perez, Edith A

publication date

  • May 20, 2014